Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Coming soon: Comparative effectiveness research for biotech
Wall Street Journal Health Blog, March 30, 2009
The stimulus package includes $1.1 billion in funding for so-called comparative-effectiveness research aimed at determining which treatment works best for a given medical condition. Now the NIH has published a list of high-priority projects it wants to fund, providing a clearer picture of just how that money may be spent. The list suggests scrutiny for some of the best-selling drugs for heart conditions and asthma, among others.
Most Viewed
Most Emailed
- $6.4B Henry Ford, Beaumont Merger Failed on Cultural Hurdles
- Fortunately, Angelina Jolie Isn't On Medicare
- Don't Let Nurses Sink Your Bottom Line
- Hospitals Profit On Bloodstream Infections
- How Chargemaster Data May Affect Hospital Revenue
- House Lawmakers Grill CMS Over Health Exchange Navigators
- Less Blood Testing for Some Surgeries Safe, Cost Effective
- Primary Care Docs Average More Hospital Revenue Than Specialists
- ED Physicians Key to Half of Hospital Admissions
- Lower ED Margins Demand a Better Strategy
